مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

318
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

173
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

GNRH ANTAGONIST VERSUS AGONIST IN NORMORESPONDERS UNDERGOING ICSI: A RANDOMIZED CLINICAL TRIAL IN IRAN

Pages

  171-176

Abstract

 Background: General concern is that the pregnancy rate is higher with GnRH-agonist as a protocol of pituitary suppression. GnRH-antagonist protocol provides a shorter period of administration and an easy flexible protocol.Objective: In this study, the outcomes of GNRH AGONIST and antagonist in ICSI cycles are compared in normo responder patients.Materials and Methods: In this randomized clinical trial, 300 NORMORESPONDERs undergoing ICSI were randomly divided to GNRH AGONIST (n=150) and GNRH ANTAGONIST (n=150) groups. The main outcome measurements were chemical, clinical and ongoing pregnancy rates (PR).Results: The mean duration of stimulation were 9.6±1.6 and 8.2±1.6 days in agonist and antagonist groups respectively (p=0.001). The mean number of MII oocyte retrieved in agonist and antagonist groups were 7.7±4.0 and 6.9±4.3 respectively (p=0.03). There was no significant difference between two groups regarding mean number of gonadotrophin ampoules, follicles, occytes, total embryos and good quality embryos, OHSS incidence, and abortion rate. Chemical pregnancy rate was 35.3% in agonist and 39.3% in antagonist group. Clinical pregnancy rate was 35.3% in agonist and 34% in antagonist group. Ongoing pregnancy rate was 45 (31.3%) in agonist and 44 (29.3%) in antagonist group. There was no significant difference between two groups in pregnancy rates.Conclusion: In this study antagonist protocol was shown to be an easy, safe and friendly protocol in Iranian NORMORESPONDER patients, having similar outcomes with standard agonist protocol but shorter period of stimulation.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    TEHRANINEJAD, ENSIEH, GHAHGHAEI NEZAMABADI, AKRAM, RASHIDI, BATOOL, SOHRABI, MARYAM, BAGHERI, MARYAM, HAGHOLLAHI, FEDYEH, AZIMI NEKOO, ELHAM, & JAFARABADI, MINA. (2011). GNRH ANTAGONIST VERSUS AGONIST IN NORMORESPONDERS UNDERGOING ICSI: A RANDOMIZED CLINICAL TRIAL IN IRAN. INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE), 9(3), 171-176. SID. https://sid.ir/paper/295832/en

    Vancouver: Copy

    TEHRANINEJAD ENSIEH, GHAHGHAEI NEZAMABADI AKRAM, RASHIDI BATOOL, SOHRABI MARYAM, BAGHERI MARYAM, HAGHOLLAHI FEDYEH, AZIMI NEKOO ELHAM, JAFARABADI MINA. GNRH ANTAGONIST VERSUS AGONIST IN NORMORESPONDERS UNDERGOING ICSI: A RANDOMIZED CLINICAL TRIAL IN IRAN. INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE)[Internet]. 2011;9(3):171-176. Available from: https://sid.ir/paper/295832/en

    IEEE: Copy

    ENSIEH TEHRANINEJAD, AKRAM GHAHGHAEI NEZAMABADI, BATOOL RASHIDI, MARYAM SOHRABI, MARYAM BAGHERI, FEDYEH HAGHOLLAHI, ELHAM AZIMI NEKOO, and MINA JAFARABADI, “GNRH ANTAGONIST VERSUS AGONIST IN NORMORESPONDERS UNDERGOING ICSI: A RANDOMIZED CLINICAL TRIAL IN IRAN,” INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE), vol. 9, no. 3, pp. 171–176, 2011, [Online]. Available: https://sid.ir/paper/295832/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button